|
||||
 ACT Files Documentation With FDA For Clinical Trials Using ES Cells To Treat Eye DiseaseJuly 29, 2010
Advanced Cell Technology, Inc. ("ACT"; OTCBB:ACTC) announced that it has submitted documentation and a complete response to substantively address the issues raised by the US Food and Drug Administration (FDA) in connection with the Company's plans to initiate a Phase I/II multicenter study using embryonic stem (ES) cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). In November 2009, ACT filed an Investigational New Drug (IND) Application to commence treating patients...
read full article
You may also be interested in these articles:
|
||||
|
|
||||
|
home | featured services | faq | health news | contact
This information is not designed to replace a physician's independent judgment about the appropriateness or risks of a procedure for a given patient. Always consult your doctor about your medical conditions. FirstAndHealth.com does not provide medical advice, diagnosis or treatment. All materials were gathered from publicly available 3rd party resources and are NOT approved or reviewed by medical doctors. |
